Free

Croatia Presidency Conference “Defining the healthcare ecosystem to determi...

Event Information

Share this event

Date and Time

Location

Location

University Foundation

11 Egmontstraat

1000 Brussel

Belgium

View Map

Event description

Description

Registration now open for Croatia Presidency conference - “Defining the healthcare ecosystem to determine value”

Registration is now open for EAPM’s Croatia EU Presidency Conference, to be held in Brussels on 24th March.

This will be the first in a series of three Presidency conferences the Alliance will hold during 2020 - the other two beinga bridging conference between the Croatia and Germany presidencies, and an event while Germany is at the helm.

Not only do these conferences reflect the nature of the relative presidency policies in the healthcare arena, but also act as major events during the first full year of the two new legislative bodies - the European Parliament and the European Commission.

In late 2019, Croatia outlined four key priorities for its turn as EU President - a role it tookover on New Year’s Day.

Croatian Prime Minister Andrej Plenkovic highlighted that
"a Europe that connectsis needed and that it is therefore necessary to further develop transport, energy, and digital infrastructure. The latter will have a major impact on health across the EU.

The presidency slogan, as you may know, is: “A strong Europe in a challenging world”.

So whats on the table at this event?

We know the chance exists to re-align priorities to evaluate the needs of patients, healthcare professionals and health systems to facilitate improved and safer therapies.

There is also space and necessity for enhanced collaboration between EU regulatory and payer groups.

However, there are also questions.

How does Europe reconcile rapid access to innovation while incentivising necessary continued research to demonstrating value and societal benefits of new medical products, including IVDs?

What are the differences that affect regulatory vs payer decisions?

What specific data elements would allow for efficient assessment of products providing significant benefit to patients?

Can we find an agreed European (and possibly global) approach to quantifying clinical benefit?

Are there clinical outcomes other than survival that can be agreed upon to be used in registration trials and healthcare systems?

Do all low-benefit medications need to be be licensed?

How do we best explain the need for both clinical research and ongoing data collection to patients and society and its benefit to both?


The sessions this conference include the following:

- Biomarkers and molecular diagnosis

- Prostate cancer – prevention and early diagnosis

- Orphan regulation and personalised medicine

- Realising the potential of Data: The Million European Genome Declaration and the EU Digital Strategy

- Health literacy and personalised healthcare


EAPM hopes that you will make the most of this opportunity to support the Croatia Presidency, support the goals of personalised medicine, and learn more about the issues surrounding the latter, its huge potential and how it can change the lives of millions of patients (including many of your constituents) for the better.

Share with friends

Date and Time

Location

University Foundation

11 Egmontstraat

1000 Brussel

Belgium

View Map

Save This Event

Event Saved